BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 36568753)

  • 1. Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials.
    Di Gennaro G; Licata F; Trovato A; Bianco A
    Front Public Health; 2022; 10():1003461. PubMed ID: 36568753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
    Musa J; Achenbach CJ; O'Dwyer LC; Evans CT; McHugh M; Hou L; Simon MA; Murphy RL; Jordan N
    PLoS One; 2017; 12(9):e0183924. PubMed ID: 28873092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
    Arbyn M; Smith SB; Temin S; Sultana F; Castle P;
    BMJ; 2018 Dec; 363():k4823. PubMed ID: 30518635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability and Concordance of Self- Versus Clinician- Sampling for HPV Testing among Rural South Indian Women.
    Madhivanan P; Nishimura H; Ravi K; Pope B; Coudray M; Arun A; Krupp K; Jayakrishna P; Srinivas V
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):971-976. PubMed ID: 33773563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions targeted at women to encourage the uptake of cervical screening.
    Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.
    Shin HY; Lee B; Hwang SH; Lee DO; Sung NY; Park JY; Jun JK
    J Gynecol Oncol; 2019 Sep; 30(5):e76. PubMed ID: 31328458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions to increase the uptake of cervical cancer screening in low- and middle-income countries: a systematic review and meta-analysis.
    Tin KN; Ngamjarus C; Rattanakanokchai S; Sothornwit J; Aue-Aungkul A; Paing AK; Pattanittum P; Jampathong N; Lumbiganon P
    BMC Womens Health; 2023 Mar; 23(1):120. PubMed ID: 36959632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials.
    Tesfahunei HA; Ghebreyesus MS; Assefa DG; Zeleke ED; Acam J; Joseph M; Getachew E; Kajogoo VD; Bekele D; Manyazewal T
    Infect Agent Cancer; 2021 Jun; 16(1):43. PubMed ID: 34147103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis.
    Yeh PT; Kennedy CE; de Vuyst H; Narasimhan M
    BMJ Glob Health; 2019; 4(3):e001351. PubMed ID: 31179035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability and Preference for Human Papilloma Virus Self-Sampling among Thai Women Attending National Cancer Institute.
    Ploysawang P; Pitakkarnkul S; Kolaka W; Ratanasrithong P; Khomphaiboonkij U; Tipmed C; Seeda K; Pangmuang P; Sangrajrang S
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):607-612. PubMed ID: 36853311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh TP; Pardee DJ; McLean SA; Panther LA; Gelman M; Mimiaga MJ; Potter JE
    PLoS One; 2018; 13(3):e0190172. PubMed ID: 29538411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis.
    Mekuria SF; Timmermans S; Borgfeldt C; Jerkeman M; Johansson P; Linde DS
    Syst Rev; 2023 Jun; 12(1):103. PubMed ID: 37349822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
    Snijders PJ; Verhoef VM; Arbyn M; Ogilvie G; Minozzi S; Banzi R; van Kemenade FJ; Heideman DA; Meijer CJ
    Int J Cancer; 2013 May; 132(10):2223-36. PubMed ID: 22907569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening.
    Costa S; Verberckmoes B; Castle PE; Arbyn M
    Br J Cancer; 2023 Mar; 128(5):805-813. PubMed ID: 36517552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    Fujita M; Nagashima K; Shimazu M; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Hanaoka H; Shozu M; Tsuruoka N; Kasai T; Hata A
    PLoS One; 2023; 18(6):e0286909. PubMed ID: 37289798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
    Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
    Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.
    Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Hayfron-Benjamin A; Abdul L; Simpore J; Mayaud P
    BMC Womens Health; 2017 Sep; 17(1):86. PubMed ID: 28950841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.